small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (98)
  • Capabilities (34)
  • Experience (7)
  • Insights & News (715)
  • Other Results (19)

Professionals 98 results

Evan Lewis
Evan Lewis
Associate
  • Houston
Email
+1 713-651-2785
vCard

Associate

  • Houston
Rick Quarles
Rick Quarles
Associate
  • Charlotte
Email
+1 704-350-7728
vCard

Associate

  • Charlotte
Katherine S. Bailey
Katherine S. Bailey
Associate
  • Chicago
Email
+1 312-558-3133
vCard

Associate

  • Chicago
View All Professionals

Capabilities 34 results

Practice Area

Copyright-Infringement Litigation

Practice Area

Crisis Management

Addressing a crisis in today’s climate requires both swift action and careful consideration of all potential risks. Winston & Strawn is a trusted business adviser to clients facing complex, fast-moving, high-profile crises....Read more

Practice Area

Fund Finance

We advise clients that originate, manage, and invest in broadly syndicated and middle-market corporate loans with their fund formation and capital markets fund-financing activities. Our experience includes structure and formation of CLOs, registered funds, hedge funds, listed funds, private credit funds, managed accounts, synthetic funds, SBICs, and onshore and offshore special purpose investment vehicles. Our experience spans the complete spectrum of services, including warehouse, leverage, and subscription facilities and ongoing portfolio support. Our Capital Markets Practice has extensive experience in debt and equity offerings, spin-offs, split-offs, and carve-outs, as well as securities compliance and corporate governance....Read more

Experience 7 results

Experience

|

November 11, 2024

Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B

A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies....Read more

Experience

|

January 16, 2024

Represented The Honey Pot Company Holdings, LLC, a leading better-for-you feminine care brand, in the sale of a controlling stake in the business to Compass Diversified (NYSE: CODI)

Winston & Strawn represented The Honey Pot Company Holdings, LLC (“The Honey Pot Co.”), a leading better-for-you feminine care brand in connection with the acquisition of a controlling stake in the business by Compass Diversified (NYSE: CODI) ("Compass”). Compass and The Honey Pot entered into a definitive agreement for an enterprise value of $380 million (excluding working capital and certain other adjustments upon closing). The Honey Pot Co. will continue to be led by its current leadership team and existing owners and management will retain a significant minority stake in The Honey Pot Co....Read more

Experience

|

July 1, 2021

Chart Industries's Acquisition of L.A. Turbine

Winston & Strawn LLP represented Chart Industries, Inc. (NYSE: GTLS), a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the energy and industrial gas markets, in its acquisition of L.A. Turbine for US$80M in cash (subject to certain customary adjustments). L.A. Turbine is a global leader in turboexpander design, engineering, manufacturing, assembly, and testing process for new and aftermarket equipment, with significant in-house engineering expertise. Chart now can offer a more comprehensive “one-stop-shop” solution and provide more options for its customers in a variety of applications....Read more
View All Experience

Insights & News 715 results

Capital Markets & Securities Law Watch

|

September 16, 2025

|

7 Min Read

The FCA’s New Prospectus Rules: A Bold Reset for UK Capital Markets

On 15 July 2025, the Financial Conduct Authority (FCA) released Policy Statement PS25/9, confirming the final rules under the Public Offers and Admission to Trading Regulations 2024 (POATRs). These reforms overhaul the UK’s prospectus regime, replacing the retained EU Prospectus Regulation and taking effect from 19 January 2026. The new framework aims to simplify capital raising, reduce costs for issuers and enhance the UK’s competitiveness as a listing venue. 

The FCA’s reforms are part of a broader government strategy to ensure regulation is targeted, proportionate and growth-oriented. They follow extensive consultation, including CP24/12 and CP25/2, and reflect recommendations from Lord Hill’s UK Listing Review and the Secondary Capital Raising Review.

Direct Sellers Update: Regulation, Law & Policy

|

August 11, 2025

|

10+ Min Read

Robinson-Patman Act Enforcement in the Direct-Selling Industry: A Clearer Look

With renewed enforcement of the Robinson-Patman Act against illegal price discrimination looming, direct-selling companies should reassess their pricing models. The FTC has made clear that tiered wholesale pricing, which gives higher-ranked distributors more favorable terms than their lower-ranked counterparts, can create significant legal risks under antitrust laws.

Non-Fungible Insights: Blockchain Decrypted

|

July 21, 2025

|

10+ Min Read

Real GENIUS: Landmark U.S. Federal Payment Stablecoin Legislation

On July 18, 2025, President Donald Trump signed into law the Guiding and Establishing National Innovation for U.S. Stablecoins Act of 2025 (the GENIUS Act or the Act), following its bipartisan passage by the Senate on June 17 (68–30) and the House on July 17 (308–122). 

View All Insights & News

Other Results 19 results

Site Content

What Is a Design Defect?

In the product liability context, a design defect claim arises when a plaintiff alleges that a product is inherently dangerous due to its design, rendering it unreasonably unsafe for its intended use. This type of claim does not focus on manufacturing errors but instead asserts that the product's fundamental design flaw poses an unreasonable risk of harm to consumers....Read more

Site Content

What Is GIPA?

The Illinois Genetic Information Privacy Act (GIPA), enacted in 1998, prohibits employers and their agents from conditioning employment on genetic data, or from using genetic data in discriminatory ways. The statute also prohibits insurers from seeking genetic information to use in connection with accident or health insurance policies....Read more

Site Content

What Is the Cooling-Off Period for an IPO?

The cooling-off period is the period of time between the public filing of a registration statement with the SEC and the date the registration statement becomes effective. During this period, no sales may take place. Written offers may only be made with a prospectus meeting the requirements of Section 10 of the Securities Act. Certain oral offers including roadshow presentations may occur during this time along with testing the waters (TTW) activities with certain potential investors.  ...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising